We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to CD4

CD4 — IBD9

Text-mined interactions from Literome

Iijima et al., J Exp Med 1999 (Inflammatory Bowel Diseases) : These findings suggest that IL-4 producing Th2-type CD4 ( + ) betabeta T cells play a major immunopathological role in the induction of IBD in TCR-alpha ( -/- ) mice, a role that anti-IL-4 mAb inhibits by causing Th2-type CD4 ( + ) betabeta T cells to shift to the Th1 type
Trobonjaca et al., J Immunol 2001 (Colitis...) : These data indicate that MHC-II dependent as well as MHC-II independent CD4 ( + ) T cells can induce a severe and lethal IBD in congenic, immunodeficient hosts, but that the former need the latter to express its IBD inducing potential
Uraushihara et al., J Immunol 2003 (Chronic Disease...) : Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid induced TNF receptor family related gene+ regulatory T cells
Maloy et al., J Intern Med 2008 (Inflammatory Bowel Diseases) : The prevailing dogma that IBD was mediated by interleukin (IL)-12-driven T-helper ( Th ) 1 CD4 T cell responses towards the bacterial flora has been largely dispelled by findings that the closely related cytokine IL-23 appears to be the key mediator of intestinal inflammation
Liu et al., Inflamm Bowel Dis 2009 (Inflammatory Bowel Diseases) : IL-21 enhances IBD NK cell cytotoxic response, triggers T cells to produce proinflammatory cytokines, and induces IBD CD4 ( + ) T cells to differentiate into Th17 cells, suggesting that IL-21 is involved in the pathogenesis of IBD and that blocking IL-21R signaling may have a therapeutic potential in IBD